1,720$
40,98%
Echtzeit-Aktienkurs Clearmind Medicine Inc.
Bid:
Ask:
Echtzeit-Chart der Clearmind Medicine Inc. Aktie
Börsenkurse Clearmind Medicine Inc.
Fundamentaldaten der Clearmind Medicine Inc. Aktie
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2022 [CAD] | - | -9,37 Mio. | -9,41 Mio. | -7,24 | - | - | - |
| 2021 [CAD] | - | -3,90 Mio. | -3,90 Mio. | -4,21 | - | - | - |
| 2020 [CAD] | - | -0,23 Mio. | -0,23 Mio. | -0,43 | - | - | - |
| 2019 [CAD] | - | -0,11 Mio. | -0,11 Mio. | -0,28 | - | - | - |
| 2018 [CAD] | - | -0,19 Mio. | -0,19 Mio. | -0,60 | - | - | - |
| 2017 [CAD] | - | -0,01 Mio. | -0,01 Mio. | -0,02 | - | - | - |
| Die Multiples wie die KGVs werden mit der Bilanzwährung und dem Kurs des ausgewählten Börsenplatzes berechnet. Wählen Sie den Börsenplatz mit der Bilanzwährung aus, damit die Multiples korrekt sind. Die fundamentalen Daten werden von Facunda geliefert; Multiples werden mit dem aktuellen Kurs berechnet. |
Profil der Clearmind Medicine Inc. Aktie
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. It focuses on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The firm intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio. The company was founded on July 18, 2017 and is headquartered in Vancouver, Canada.